Clincosm LogoSign in Get a demo

Hepatocellular Carcinoma

Showing NaN - NaN of 46
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Direct Acting Antiviral-Post Authorization Safety Study

Completed
  • Hepatitis C
  • Hepatocellular Carcinoma
    • Phoenix, Arizona
    • +61 more
    Jul 1, 2021

    Hepatocellular Carcinoma Trial in Worldwide (Tivantinib, Placebo)

    Completed
    Has Results
    • Hepatocellular Carcinoma
    • Tucson, Arizona
    • +112 more
    Mar 12, 2021

    Biomarkers for Hepatocellular Carcinoma

    Completed
    • Hepatocellular Carcinoma
    • Hepatocellular Carcinoma Surveillance
    • Blood Sample Collection
    • Los Angeles, California
    • +73 more
    Aug 4, 2020

    Hepatocellular Carcinoma Trial in Philadelphia (HCQ)

    Terminated
    Has Results
    • Hepatocellular Carcinoma
    • Philadelphia, Pennsylvania
      Abramson Cancer Center of the University of Pennsylvania
    Apr 7, 2020

    Hepatocellular Carcinoma Trial in Canada, United Kingdom, United States (SGI-110)

    Completed
    Has Results
    • Hepatocellular Carcinoma
    • Duarte, California
    • +23 more
    Jan 13, 2020

    The Second Multicenter Hemophilia Cohort Study

    Completed
    • Liver Decompensation
    • +2 more
      • Tucson, Arizona
      • +47 more
      Dec 14, 2019

      Hepatocellular Carcinoma Trial in Worldwide (ADI-PEG 20 (arginine deiminase formulated with polyethylene glycol), Placebo, Best

      Completed
      • Hepatocellular Carcinoma
      • ADI-PEG 20 (arginine deiminase formulated with polyethylene glycol)
      • +2 more
      • Birmingham, Alabama
      • +72 more
      Aug 27, 2019

      Hepatocellular Carcinoma Trial in Worldwide (Axitinib (AG-013736), Best Supportive Care, Placebo)

      Completed
      Has Results
      • Hepatocellular Carcinoma
      • Axitinib (AG-013736)
      • +2 more
      • Berkeley, California
      • +76 more
      Dec 20, 2018

      Breast Cancer, Lung Cancer, Pancreatic Cancer Trial in United States (INO-1400, INO-9012, INO-1401)

      Completed
      • Breast Cancer
      • +8 more
      • INO-1400
      • +2 more
      • Detroit, Michigan
      • +5 more
      Nov 15, 2018

      Hepatocellular Carcinoma Trial in United States (IMC-A12 (cixutumumab) - 10 milligrams/kilogram (mg/kg), IMC-A12 (cixutumumab) -

      Completed
      Has Results
      • Hepatocellular Carcinoma
      • IMC-A12 (cixutumumab) - 10 milligrams/kilogram (mg/kg)
      • +2 more
      • Scottsdale, Arizona
      • +6 more
      May 1, 2018

      Adult-to-Adult Living Donor Liver Transplantation Study

      Completed
      • Cirrhosis
      • +2 more
        • Los Angeles, California
        • +8 more
        Aug 27, 2017

        Hepatocellular Carcinoma Trial in Worldwide (ThermoDox, 5% Dextrose Solution)

        Completed
        Has Results
        • Hepatocellular Carcinoma
        • Los Angeles, California
        • +78 more
        Mar 24, 2017

        Hepatitis C, Hepatocellular Carcinoma Trial in New Zealand, Spain, United States (Sofosbuvir, Ribavirin)

        Completed
        Has Results
        • Hepatitis C
        • Hepatocellular Carcinoma
        • Los Angeles, California
        • +14 more
        Jun 16, 2016

        Hepatocellular Carcinoma Trial in Worldwide (Placebo, Ramucirumab DP (IMC-1121B), BSC)

        Completed
        Has Results
        • Hepatocellular Carcinoma
        • Placebo
        • +2 more
        • Orange, California
        • +145 more
        Nov 24, 2015

        Hepatocellular Carcinoma Trial in United States (Sorafenib Standard Dosing Regimen, Sorafenib Ramp-Up Regimen)

        Completed
        Has Results
        • Hepatocellular Carcinoma
        • Sorafenib Standard Dosing Regimen
        • Sorafenib Ramp-Up Regimen
        • Gainesville, Florida
        • +8 more
        Feb 13, 2015

        Hepatocellular Carcinoma Trial in United States (Ramucirumab (IMC-1121B))

        Completed
        Has Results
        • Hepatocellular Carcinoma
        • Ramucirumab (IMC-1121B)
        • Los Angeles, California
        • +5 more
        Sep 29, 2014

        Hepatocellular Carcinoma Trial in Taiwan, United States (GC33(RO5137382), Sorafenib)

        Completed
        • Hepatocellular Carcinoma
        • San Francisco, California
        • +6 more
        Oct 1, 2014

        Hepatocellular Carcinoma, Liver Cancer, Localized Unresectable Liver Cancer Trial in Philadelphia (sorafenib tosylate,

        Completed
        • Hepatocellular Carcinoma
        • +2 more
        • sorafenib tosylate
        • +5 more
        • Philadelphia, Pennsylvania
          Abramson Cancer Center of The University of Pennsylvania
        Feb 25, 2013

        Hepatocellular Carcinoma Trial in United States (mapatumumab, sorafenib)

        Completed
        • Hepatocellular Carcinoma
        • Los Angeles, California
        • +5 more
        Oct 26, 2012

        Hepatocellular Carcinoma Trial in China, United States (intravenous T900607-sodium)

        Unknown status
        • Hepatocellular Carcinoma
        • intravenous T900607-sodium
        • La Jolla, California
        • +11 more
        Jun 23, 2005

        Hepatocellular Carcinoma Trial in Worldwide (T138067 intravenous, doxorubicin intravenous)

        Terminated
        • Hepatocellular Carcinoma
        • T138067 intravenous
        • doxorubicin intravenous
        • Birmingham, Alabama
        • +75 more
        Jun 23, 2005